Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali

被引:68
作者
Gu, YC
Wang, GJ
Pan, GY
Fawcett, JP
Jiye, A
Sun, JG
机构
[1] Univ Otago, Sch Pharm, Dunedin, New Zealand
[2] China Pharmaceut Univ, Ctr Pharmacokinet, Nanjing, Peoples R China
关键词
D O I
10.1111/j.1742-7843.2004.t01-1-pto950508.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Astragaloside IV is an important constituent of Radix Astragali, a herbal remedy widely used in traditional Chinese medicine. Radix Astragali is administered orally but little is known about the transport properties and bioavailability of astragaloside IV In this paper we report studies of the absorption of astragaloside IV in the perfused rat intestinal model, transport and uptake in Caco-2 cell monolayers and in vivo bioavailability in rat after an oral dose. In the perfused rat intestinal model, absorption of astragaloside IV was low from an aqueous solution but was significantly higher from a solution of Radix Astragali. Absorption was not affected by bile duct ligation. Transport through Caco-2 cells gave a very low permeability value (mean P-app of 6.7 +/- 1.0 10(-8) cm/sec.) and uptake was unaffected by P-glycoprotein inhibitors. The absolute bioavailability of astragaloside IV in rat was 2.2%. The correlation between low permeability in vitro and poor bioavailability in vivo indicates in vitro absorption studies are useful in the evaluation of traditional Chinese medicines.
引用
收藏
页码:295 / 298
页数:4
相关论文
共 16 条
[1]   Balicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form [J].
Akao, T ;
Kawabata, K ;
Yanagisawa, E ;
Ishihara, K ;
Mizuhara, Y ;
Wakui, Y ;
Sakashita, Y ;
Kobashi, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (12) :1563-1568
[2]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[3]  
BARTRAKOVA EV, 1998, PHARM RES, V15, P850
[4]   IN-VITRO IN-VIVO MODELS FOR PEPTIDE ORAL ABSORPTION - COMPARISON OF CACO-2 CELL-PERMEABILITY WITH RAT INTESTINAL-ABSORPTION OF RENIN INHIBITORY PEPTIDES [J].
CONRADI, RA ;
WILKINSON, KF ;
RUSH, BD ;
HILGERS, AR ;
RUWART, MJ ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1993, 10 (12) :1790-1792
[5]   Determination of Astragaloside IV in rat plasma by liquid chromatography electrospray ionization mass spectrometry [J].
Gu, YC ;
Wang, GJ ;
Fawcett, JP .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 801 (02) :285-288
[6]   CACO-2 CELL MONOLAYERS AS A MODEL FOR DRUG TRANSPORT ACROSS THE INTESTINAL-MUCOSA [J].
HILGERS, AR ;
CONRADI, RA ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1990, 7 (09) :902-910
[7]  
IKUMI T, 1997, J PHARMACOL EXP THER, V283, P108
[8]  
KIM DC, 1993, PHARMACEUT RES, V10, P1710
[9]   Saturable transport of H2-antagonists ranitidine and famotidine across Caco-2 cell monolayers [J].
Lee, K ;
Thakker, DR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (07) :680-687
[10]   Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo [J].
Lennernas, H ;
Palm, K ;
Fagerholm, U ;
Artursson, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 127 (01) :103-107